Trials / Conditions / Locally Advanced or Metastatic Pancreatic Cancer
Locally Advanced or Metastatic Pancreatic Cancer
5 registered clinical trials studyying Locally Advanced or Metastatic Pancreatic Cancer — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Evaluation of Safety and Efficacy in BEY1107 in Monotherapy Gemcitabine Combination in Patient with Pancreatic NCT03579836 | BeyondBio Inc. | Phase 1 / Phase 2 |
| Completed | SLOG vs mFOLFIRINOX as the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic Can NCT03443492 | National Health Research Institutes, Taiwan | Phase 2 |
| Completed | Masitinib Plus Gemcitabine in Pancreatic Cancer NCT03766295 | AB Science | Phase 3 |
| Completed | A Phase 1 Study of Safety and Bioactivity With FG-3019 in Combination With Gemcitabine and Erlotinib for Subje NCT01181245 | Kyntra Bio | Phase 1 |
| Completed | Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic Cancer NCT00651742 | Taiho Oncology, Inc. | Phase 2 |